CTU vs IVU Scans for Bladder Cancer

Recruiting in Palo Alto (17 mi)

Overseen ByChaan Ng, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: M.D. Anderson Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this clinical research study is to use computed tomography urography (CTU) scans and intravenous urography (IVU) scans to check the status of urothelial cancer, in order to try to learn the level of effectiveness of possibly using CTU by itself in future patients.

Eligibility Criteria

This trial is for adults over 18 with confirmed urothelial cancer, including those who've had bladder tumors of Stage T3 or higher, cystectomies for bladder cancer, or upper tract TCC. Participants must consent and be referred for CTU as part of routine care. It's not suitable for individuals with high serum creatinine levels (>2), contrast media allergies, women who could become pregnant, or those who have had a ureteral stint placed or removed within six weeks.

Inclusion Criteria

I had surgery to remove my bladder due to cancer.

I am scheduled for IVU with digital tomosynthesis and a CT scan as part of my routine care.

I have cancer in the upper part of my urinary system.

+5 more

Exclusion Criteria

I am a woman who could become pregnant.

I am allergic to IV dye used in CT scans.

I have had a ureteral stent placed or removed in the last six weeks.

+1 more

Participant Groups

The study compares the effectiveness of Computed Tomography Urography (CTU) versus Intravenous Urography (IVU) in evaluating urothelial cancers. The aim is to determine if CTU can be used alone to assess these cancers effectively in future patients.

1Treatment groups

Experimental Treatment

Group I: CTU + IVUExperimental Treatment2 Interventions

CTU = Computed Tomography Urography + IVU = Intravenous Urography